479 related articles for article (PubMed ID: 24416617)
1. Melanoma: from melanocyte to genetic alterations and clinical options.
Bertolotto C
Scientifica (Cairo); 2013; 2013():635203. PubMed ID: 24416617
[TBL] [Abstract][Full Text] [Related]
2. Melanocytes in development and cancer.
Uong A; Zon LI
J Cell Physiol; 2010 Jan; 222(1):38-41. PubMed ID: 19795394
[TBL] [Abstract][Full Text] [Related]
3. Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.
Dutton-Regester K; Hayward NK
Adv Pharmacol; 2012; 65():399-435. PubMed ID: 22959033
[TBL] [Abstract][Full Text] [Related]
4. Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.
Mordoh A; Triviño Pardo JC; Carri I; Barrio MM; Mordoh J; Aris M
BMC Med Genomics; 2023 Jan; 16(1):1. PubMed ID: 36604730
[TBL] [Abstract][Full Text] [Related]
5. From bedside to bench and back: Translating ASD models.
Drozd HP; Karathanasis SF; Molosh AI; Lukkes JL; Clapp DW; Shekhar A
Prog Brain Res; 2018; 241():113-158. PubMed ID: 30447753
[TBL] [Abstract][Full Text] [Related]
6. Metastatic melanoma: a regional review and future directions.
Khan KH; Goody RB; Hameed H; Jalil A; Coyle VM; McAleer JJ
Tumori; 2012; 98(5):575-80. PubMed ID: 23235751
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Melanoma immunotherapy dominates the field.
Diamantopoulos P; Gogas H
Ann Transl Med; 2016 Jul; 4(14):269. PubMed ID: 27563656
[TBL] [Abstract][Full Text] [Related]
9. Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
Testa U; Castelli G; Pelosi E
Med Sci (Basel); 2017 Nov; 5(4):. PubMed ID: 29156643
[TBL] [Abstract][Full Text] [Related]
10. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of normal melanocytes and melanoma cells.
Bandarchi B; Jabbari CA; Vedadi A; Navab R
J Clin Pathol; 2013 Aug; 66(8):644-8. PubMed ID: 23526597
[TBL] [Abstract][Full Text] [Related]
12. Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer.
Lindsay CR; Spiliopoulou P; Waterston A
Ther Adv Med Oncol; 2015 Mar; 7(2):107-21. PubMed ID: 25755683
[TBL] [Abstract][Full Text] [Related]
13. Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review.
Naik PP
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1481-1496. PubMed ID: 34339016
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
15. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
16. From melanocyte to metastatic malignant melanoma.
Bandarchi B; Ma L; Navab R; Seth A; Rasty G
Dermatol Res Pract; 2010; 2010():. PubMed ID: 20936153
[TBL] [Abstract][Full Text] [Related]
17. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
18. BRAF and beyond: Tailoring strategies for the individual melanoma patient.
Jarkowski A; Khushalani NI
J Carcinog; 2014; 13():1. PubMed ID: 24737949
[TBL] [Abstract][Full Text] [Related]
19. Melanoma Management: From Epidemiology to Treatment and Latest Advances.
Lopes J; Rodrigues CMP; Gaspar MM; Reis CP
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230575
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma.
Mallone F; Sacchetti M; Lambiase A; Moramarco A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
